Status:

COMPLETED

Multimodal Correction of Post-stroke Motor and Cognitive Impairments

Lead Sponsor:

Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine

Collaborating Sponsors:

Moscow Government

Conditions:

Stroke Rehabilitation

Eligibility:

All Genders

45-75 years

Phase:

NA

Brief Summary

The aim of the study is the development and scientific substantiation of the effectiveness and safety of multimodal rehabilitation technology using innovative digital technologies, biofeedback (BFB), ...

Detailed Description

The object of the study The study will include 90 patients (men and women) with the diagnosis of ischemic stroke (IS) in the early recovery (up to 6 months) and late recovery (6-12 months) periods wit...

Eligibility Criteria

Inclusion

  • Men or women aged 45 to 70 years after a first-onset IS, early (1-6 months), late recovery (6-12 months) periods.
  • Supratentorial IS according to MRI of the brain.
  • The severity of UL paresis ranged from a score of 4 to 3 according to the Medical Research Council Scale (MRCS).20
  • Spasticity of 2 points or less by the Modified Ashworth Scale (MAS)
  • Cognitive function more than 20 points on the Montreal Cognitive Assessment (MoCA)
  • Affective disorders score less than 11 on the Hospital Anxiety and Depression Scale (HADS)
  • The patient's ability and willingness to comply with the requirements of this protocol.

Exclusion

  • Concomitant neurological diseases causing decreased muscle strength or increased muscle tone in the UL (e.g., cerebral palsy, brain injury).
  • Clinically significant limitation of the passive movement amplitude in the joints of the investigated hand, pronounced contracture and deformities of the upper extremity.
  • Use of other DIT, BFB techniques to restore impaired UL function within 30 days prior to the patient Inclusion Visit.
  • Severe visual impairment, decreased visual acuity of less than 0.2 in the worst eye according to the Golovin-Sivtsev Table24.
  • Sensory aphasia, gross motor aphasia.
  • Recurrent stroke.
  • Epilepsy
  • Unstable angina and/or heart attack in previous month.
  • Uncontrolled arterial hypertension.
  • Somatic diseases in decompensation stage.
  • Thrombosis of deep and superficial veins of the lower extremities
  • The presence of left-handedness in the patient according to the Edinburgh manual asymmetry questionnaire
  • Alcohol abuse, medical marijuana use or soft drug abuse within the 12 months prior to the Inclusion Visit.
  • Any medical condition, including mental disease or epilepsy that could affect the interpretation of study results, the study procedures or patient safety.
  • 15 Pregnancy. 16. Lactation.
  • \-

Key Trial Info

Start Date :

March 17 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 31 2023

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT05391919

Start Date

March 17 2022

End Date

May 31 2023

Last Update

September 14 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine, branch 7

Moscow, Russia, 105120